Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (209)	8/16/2000 2:16:55 PM
From: tuck	Read Replies (2) \| Respond to of 1833

Rick, If this is what has caused the sell-off, then this should be a buying op, as it is old news. siliconinvestor.com Heretical thought: Suppose Mr. Icahn is content to let the wheels of justice grind slowly. For if OSIP comes up with something good from the Cadus technology it would enhance the size of an award should Cadus win the patent dispute with Sibia. It will take time for this to develop. But Mr. Icahn might trying to get his technology developed with other people's money, then get his chunk from a win in court/PTO. Of course, if the PTO is bound to rule before OSIP has had a chance to start using their Cadus technology, this is idea all wet. Your thoughts on that timing? Whatever he's up to, the price looks attractive relative to cash. Methinks I'll double up here. Cheers, Tuck